1. Pink Sheet
  2. >>Compliance
  3. >>Marketing & Advertising

Power Toothbrushes Engage Kids, Collect Data With Digital Apps

 
• By Eileen Francis

Colgate Smart Electronic Toothbrush E1 is available exclusively on Apple.com and in select Apple stores for $99.95. The product is similar to a device sold in Europe by French firm Kolibree, which also introduced a children’s smart toothbrush featuring augmented reality to encourage brushing.

French digital technology firm Kolibree SAS is following up its collaboration on Colgate-Palmolive Co.'s launch of a power toothbrush featuring artificial intelligence to improve brushing with a children’s device containing an augmented reality app to “gamify” brushing.

Kolibree, which provided AI technology for the recently launched ColgateSmart Electronic Toothbrush E1, says its Magik children's brush "bridges the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

US FDA’s Advertising Enforcement Crackdown Expands To Generic Drugs

 
• By Sue Sutter

A webpage for PharmaTher’s ketamine product lacked risk information and made misleading claims about the approved indication, the FDA said in a rare ad/promo violation letter to an ANDA holder.

New Zealand To Approve Drugs In Just 30 Days Under ‘Rule of Two’ Policy

 
• By Neena Brizmohun

New Zealand is also lifting its prohibition on advertising unapproved medicines at medical conferences and trade shows in order to boost its appeal as a host for such events and generate millions of dollars in revenue.

Pfizer’s Advertising Challenge Against BridgeBio’s Attruby Leverages US FDA Untitled Letter

 
• By Sue Sutter

Pfizer, which markets Vyndamax for transthyretin amyloid cardiomyopathy, said an FDA violation letter shows BridgeBio made false and misleading superiority claims, but BridgeBio refused to participate in the National Advertising Division process.

MLR Reviews: How To “Shift Left” With Agentic AI, Balance Compliance And Creativity

 
• By Vibha Ravi

Experts from UCB, Alnylam, Lantheus and Medtronic deliberate on the best use of agentic AI in the MLR review process, its human replaceability quotient and ways to balance creativity with compliance, a significant discussion amid DTC advertising and US FDA scrutiny

More from Compliance

Generic Drug Onshoring: Bipartisan Support For Federal Procurement Reforms

 
• By Laura Helbling

A Senate hearing on the medical product supply chain suggests there is bipartisan support for ‘buy American’ policies for federal Rx purchases, and for country-of-origin labeling to help those policies expand to the private sector.

New Zealand To Approve Drugs In Just 30 Days Under ‘Rule of Two’ Policy

 
• By Neena Brizmohun

New Zealand is also lifting its prohibition on advertising unapproved medicines at medical conferences and trade shows in order to boost its appeal as a host for such events and generate millions of dollars in revenue.

‘Why We Would Do It Again’ – Gilead & Roche On Pioneering Global Initiative For Manufacturing Change

 
• By Vibha Sharma

Gilead and Roche reflect on their experiences with a global initiative that delivered aligned regulatory decisions through joint hybrid inspections and synchronized review of post-approval changes.